Cases & Deals

Guided Therapeutics issues $3 million of Senior Convertible Notes in private placement

Clients Guided Therapeutics, Inc.

Jones Day advised Guided Therapeutics, Inc., a medical device company developing a biophotonic cancer detection testing platform, in connection with its issuance of $3 million in aggregate principal amount of 6% Senior Convertible Notes in a private placement to an institutional investor.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.